Usana Health's stock dips then turns flat after earnings miss and lowered guidance
Usana Health Sciences Inc.'s stock (USNA) fell 2% before turning flat in after-hours trade Tuesday, after the maker of nutritional supplements missed earnings estimates for the third quarter. Salt Lake City, Utah-based Usana posted net income of $11.3 million, or 59 cents a share, for the quarter, down from $14.9 million, or 78 cents a share, in the year-earlier period. Sales fell to $213.4 million from $233.3 million. The FactSet consensus was for EPS of 64 cents and revenue of $220.0 million. "Operating results for the third quarter did not meet our expectations, largely because of challenging economic conditions across many of our regions and a lower cadence of promotional activity during the quarter," CEO John Brown said in a statement. "These factors made it difficult to generate both Active Customer growth and top line momentum in our business." The company lowered its full-year guidance and now expects EPS to range from $2.80 to $3.05, compared with prior guidance of $2.65 to $3.30. It expects sales of $900 million to $920 million, compared with prior guidance of $900 million to $950 million. The stock has gained 4% in the year to date, while the S&P 500 has gained 10.6%.
-Ciara Linnane
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
10-24-23 1625ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks